Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/53196
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKang, L.en
dc.contributor.authorCrawford, N.en
dc.contributor.authorTang, M.en
dc.contributor.authorButtery, J.en
dc.contributor.authorRoyle, J.en
dc.contributor.authorGold, M.en
dc.contributor.authorZiegler, C.en
dc.contributor.authorQuinn, P.en
dc.contributor.authorElia, S.en
dc.contributor.authorChoo, S.en
dc.date.issued2008en
dc.identifier.citationBritish Medical Journal, 2008; 337(a2642):1-5en
dc.identifier.issn0959-535Xen
dc.identifier.issn0959-8146en
dc.identifier.urihttp://hdl.handle.net/2440/53196-
dc.description.abstractOBJECTIVE: To describe the outcomes of clinical evaluation, skin testing, and vaccine challenge in adolescent schoolgirls with suspected hypersensitivity to the quadrivalent human papillomavirus vaccine introduced in Australian schools in 2007. DESIGN: Retrospective cohort study. SETTING: Two tertiary paediatric allergy centres in Victoria and South Australia, Australia. PARTICIPANTS: 35 schoolgirls aged 12 to 18.9 years with suspected hypersensitivity reactions to the quadrivalent human papillomavirus vaccine. MAIN OUTCOME MEASURES: Clinical review and skin prick and intradermal testing with the quadrivalent vaccine and subsequent challenge with the vaccine. RESULTS: 35 schoolgirls with suspected hypersensitivity to the quadrivalent human papillomavirus vaccine were notified to the specialised immunisation services in 2007, after more than 380 000 doses had been administered in schools. Of these 35 schoolgirls, 25 agreed to further evaluation. Twenty three (92%) experienced reactions after the first dose. Thirteen (52%) experienced urticaria or angio-oedema, and of these, two experienced anaphylaxis. Thirteen had generalised rash, one with angio-oedema. The median time to reaction was 90 minutes. Nineteen (76%) underwent skin testing with the quadrivalent vaccine: all were skin prick test negative and one was intradermal test positive. Eighteen (72%) were subsequently challenged with the quadrivalent vaccine and three (12%) elected to receive the bivalent vaccine. Seventeen tolerated the challenge and one reported limited urticaria four hours after the vaccine had been administered. Only three of the 25 schoolgirls were found to have probable hypersensitivity to the quadrivalent vaccine. CONCLUSION: True hypersensitivity to the quadrivalent human papillomavirus vaccine in Australian schoolgirls was uncommon and most tolerated subsequent doses.en
dc.description.statementofresponsibilityLiew Woei Kang, Nigel Crawford, Mimi L K Tang, Jim Buttery, Jenny Royle, Michael Gold, Christine Ziegler, Patrick Quinn, Sonja Elia, Sharon Chooen
dc.language.isoenen
dc.publisherBritish Med Journal Publ Groupen
dc.subjectHumans; Papillomavirus Infections; Drug Hypersensitivity; Retrospective Studies; Cohort Studies; Adolescent; South Australia; Victoria; Female; Papillomavirus Vaccinesen
dc.titleHypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort studyen
dc.typeJournal articleen
dc.identifier.rmid0020084098en
dc.identifier.doi10.1136/bmj.a2642en
dc.identifier.pubid40953-
pubs.library.collectionPaediatrics publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidGold, M. [0000-0003-1312-5331]en
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.